Romagnat, France

Jean-Claude Madelmont

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1991-2006

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jean-Claude Madelmont: A Visionary Inventor in the World of Technology

Introduction: Jean-Claude Madelmont, a visionary inventor hailing from Romagnat, FR, has left an indelible mark on the world of technology and innovation. With a total of 4 patents under his belt, his relentless pursuit of excellence and passion for innovation continue to inspire future generations of inventors and innovators.

Latest Patents: Among his latest patents is the development of Quaternary ammonium compounds - a groundbreaking compound with formula (Ia) or (Ib), designed for the treatment or diagnosis of pathologies caused by cartilage attack. This innovation showcases Madelmont's commitment to pushing the boundaries of medical science.

Career Highlights: Jean-Claude Madelmont has made significant contributions to renowned companies such as the Institut National de la Santé et de la Recherche Médicale (Inserm) and Cis Bio International. His innovative spirit and dedication to his craft have led to the creation of cutting-edge technologies that have revolutionized the healthcare industry.

Collaborations: Throughout his illustrious career, Madelmont has collaborated with esteemed professionals such as Marie-France Moreau and Denise Godeneche. These partnerships have not only enriched his work but have also paved the way for groundbreaking advancements in the field of medical research.

Conclusion: Jean-Claude Madelmont's unwavering commitment to innovation and his remarkable contributions to the world of technology solidify his legacy as a visionary inventor. His work continues to shape the future of healthcare and inspires aspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…